Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

• Autor(a) principal: Clemens, Sue Ann Costa
• Data de Publicação: 2021
• Outros Autores: Folegatti, Pedro M., Emary, Katherine R. W., Weckx, Lily Yin, Ratcliff, Jeremy, Bibi, Sagida, Mendes, Ana Verena de Almeida, Milan, Eveline Pipolo, Pittella, Ana, Schwarzbold, Alexandre V., Sprinz, Eduardo, Aley, Parvinder K., Bonsall, David, Fraser, Christophe, Fuskova, Michelle, Gilbert, Sarah C., Jenkin, Daniel, Kelly, Sarah, Kerridge, Simon, Lambe, Teresa, Marchevsky, Natalie G., Mujadidi, Yama F., Plested, Emma, Ramasamy, Maheshi N., Simmonds, Peter, Golubchik, Tanya, Voysey, Merryn, Pollard, Andrew J., AMPHEUS Project* & Oxford COVID Vaccine Trial Team
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
• Texto Completo: https://www.arca.fiocruz.br/handle/icict/49701
• topic: COVID-19; SARS-CoV-2; Vacina; Eficácia; Brasil; COVID-19; SARS-CoV-2; Vaccine; Efficacy; Brazil

SOUZA, Bruno Solano de Freitas. Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil. 1 Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. 2 Institute of Global Health, University of Siena, Siena, Italy. 3 The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. 4 Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil. 5 Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK. 6 Escola Bahiana de Medicina e Saúde Pública, Brazil and ID’OR, Salvador, Brazil. 7 Hospital São Rafael, Salvador, Brazil. 8 Universidade Federal do Rio Grande do Norte - UFRN, Natal, Brazil. 9 Hospital Quinta D’Or, Rio de Janeiro, Brazil. 10 Instituto D’Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil. 11 Universidade Unigranrio, Rio de Janeiro, Brazil. 12 Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil. 13 Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil. 14 Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. 15 Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. 16 Oxford University Hospitals NHS Foundation Trust, Oxford, UK. 17 Oxford Viral Sequencing Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK. 33These authors contributed equally: Sue Ann Costa Clemens, Pedro M. Folegatti, Katherine R.W. Emary, Lily Yin Weckx, Jeremy Ratcliff, Sagida Bibi. 34These authors jointly supervised: Tanya Golubchik, Merryn Voysey, Andrew J Pollard. 19Hospital São Rafael e ID’OR, Porto Alegre, Brazil. 20Centro de Estudos e Pesquisas em Moléstias Infecciosas, Rio de Janeiro, Brazil. 21Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil. 22Universidade Federal de Sao Paulo, São Paulo, Brazil. 23Hospital Universitário de Santa Maria, Santa Maria, Brazil. 24Nuffield Department of Population Health, University of Oxford, Oxford, UK. 25Department of Clinical and Toxicological Analysis- Universidade Federal de Santa Maria, Santa Maria, Brazil. 26Monte Tabor Centro Ítalo Brasileiro de Promoção Sanitária, Fiocruz-BA e I’DOR, Rio de Janeiro, Brazil. 27Universidade Federal da Bahia, Salvador, Brazil. 28Rede D’OR, Rio De Janeiro, Brazil. 29Vaxtrials, F&F Tower, Calle 50, Panamá, Panama. 30Universidade Federal de Santa Maria, Santa Maria, Brazil. 31Nuffield Department of Medicine, University of Oxford, Oxford, UK. 32Programa de Pós Graduação em Enfermagem- PPGENF - Universidade Federal de Santa Maria, Santa Maria, Brazil.